DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
Clinical trial NCT03505710 · TERMINATED
Trial details
- NCT number
- NCT03505710
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2021-05-03
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.